Evaluation of the iNtRON VRE vanA/vanB Real-Time PCR Assay for Detection of Vancomycin-Resistant Enterococci|RISS 상세보기

다국어 초록 (Multilingual Abstract)

Background: Recently, the iNtRON VRE vanA/vanB real-time PCR (iNtRON; iNtRON Biotechnology, Korea) assay, a multiplex real-time PCR method, was introduced. In this prospective study, we compared the iNtRON assay with the Seeplex VRE ACE detection kit (Seeplex; Seegene, Korea), a conventional multiplex PCR assay.
Methods: A chromogenic agar-based culture, in which pre-selected vancomycin-resistant enterococci (VRE) was grown and subsequently plated on blood agar with vancomycin disks, was regarded as the reference method. A total of 304 consecutive rectal swab specimens were tested for VRE by culture and by iNtRON and Seeplex PCR assays. For the PCR assays, specimens were enriched for 16-24 hr before PCR.
Results: VRE were isolated from 44 (14.5%) specimens by chromogenic agar-based culture. The clinical sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the iNtRON assay were 100% (95% confidence interval: 89.8%-100%), 99.2% (96.9%-99.9%), 95.6% (83.6%-99.2%), and 100% (98.2%-100%), respectively, while those of the Seeplex assay were 97.7% (86.2%-99.9%), 99.6% (97.5%-99.9%), 97.7% (86.2%-99.9%), and 99.6% (97.5%-99.9%), respectively. The iNtRON assay had a detection limit of 3,159 copies/μL and 13,702 copies/μL for the vanA and vanB genes, respectively. No cross-reactivity was observed in 11 non-VRE bacterial culture isolates.
Conclusions: The overall performance of the iNtRON assay was comparable to that of a chromogenic agar-based culture method for prompt identification of VRE-colonized patients in hospitals. This assay could be an alternative or supportive method for the effective control of nosocomial VRE infection.

번역하기

참고문헌 (Reference)

1 원다해, "대변 감시배양에서 vanB PCR 양성이지만 vanB형 반코마이신 내성 장구균 배양 음성인 증례" 대한진단검사의학회 3 (3): 264-268, 2013

2 박일중, "vanA 유전자를 지닌 Vancomycin 내성 장구균의 VanB 표현형 발현 기전" 대한진단검사의학회 26 (26): 412-417, 2006

3 Power EG, "vanA genes in vancomycin-resistant clinical isolates of Oerskovia turbata and Arcanobacterium (Corynebacterium) haemolyticum" 36 : 595-606, 1995

4 Ligozzi M, "vanA gene cluster in a vancomycin-resistant clinical isolate of Bacillus circulans" 42 : 2055-2059, 1998

5 Steingart KR, "Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults" 1 : CD009593-, 2013

6 Sievert DM, "Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006" 46 : 668-674, 2008

7 Fontana R, "Vancomycin-resistant Bacillus circulans carrying the vanA gene responsible for vancomycin resistance in enterococci" 16 : 473-474, 1997

8 Lleò MM, "Vancomycin resistance is maintained in enterococci in the viable but nonculturable state and after division is resumed" 47 : 1154-1156, 2003

9 Courvalin P, "Vancomycin resistance in gram-positive cocci" 42 (42): S25-34, 2006

10 Perl TM, "The threat of vancomycin resistance" 106 : 26S-37S, 1999